|

505 (b)(2)
Vesta Pharmaceuticals has on-staff industry experts in the field of Abbreviated
New Drug Applications (ANDA). ANDA is the FDA's expedited process to
approve the generic pharmaceuticals that compete with innovator drugs coming off
patent protection. ANDA eliminates the need for costly clinical trials as long as the generic drug is scientifically proven as
bioequivalent to the original drug. Vesta Pharmaceuticals has experienced,
dedicated experts devoted to guiding you every step of the way through the ANDA
process.
Consumers and governments alike are pressuring the pharmaceutical industry to
produce more quality, effective prescription medications at significantly
reduced prices; therefore, demand for generic prescriptions will continue to
skyrocket. Vesta Pharmaceuticals is positioned perfectly to partner with
your company to develop, manufacture, and deliver the high-quality generic drugs
you need to propel your business' growth.
Vesta will manufacture your generic drugs in our FDA registered facility with
the utmost consistency and quality, and we deliver your product exactly when you
need it.
CLICK HERE: To
View Our VESTA® Brochure
Home | Who We Are | Contract Manufacturing | Nutritional Products Store | Industrial Use Products
Research & Development | International Distribution Partner Program | Career Opportunities | Contact Us
Copyright © 2005 - Vesta Pharmaceuticals, Inc. - All rights reserved.
|